nebacumab - CISMeF

Preferred Label : nebacumab;

MeSH note : withdrawn from clinical trials for treatment of septicemia after excess mortality; monoclonal antiendotoxin agent; USAN lists 138661-01-5 as RN for nebacumab; MW about 1000 kDa;

CISMeF synonym : 138661-01-5 (USAN 1993); HA-1A; centoxin;

MeSH synonym : septomonab; HA-1A monoclonal antibody;

MeSH Related Number : 138330-99-1;

Registry Number MeSH : 138330-99-1;

related registry number list (CISMeF) : 138661-01-5 (USAN 1993);

Is substance : O;

UNII : 908FWN27WK;

Détails

Origin ID

C068069;

UMLS CUI

C0132092;

ATC code(s)
- nebacumab [ATC Code]
Automatic exact mappings (from CISMeF team)
- HA-1A (product) [Inactive SNOMED CT concept]
CISMeF manual mappings
- Nebacumab [NCIt concept]
Currated CISMeF NLP mapping
- Nebacumab [SMS substance]
MeSH indexing information
- immunoglobulin M [MeSH Descriptor]
MeSH term(s) associated for indexing
- antibodies, monoclonal [MeSH Descriptor]
- antibodies, monoclonal, humanized [MeSH Descriptor]
Record concept(s)
- centoxin [MeSH concept]
- nebacumab [MeSH concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Immunologic Factor [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Nebacumab [NCIt concept]
- nebacumab [ATC Code]
Validated automatic mappings to BTNT
- nebacumab [ATC Code]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients